Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04382417
NCT04382417
Completed
Not Applicable

Characteristics and Outcomes of Critically Ill Patients With Covid-19 in a Large Swedish County Hospital - a Prospective Observational Cohort Study

Region Västmanland1 site in 1 country57 target enrollmentMarch 26, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCovid-19Critical Illness

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid-19
Sponsor
Region Västmanland
Enrollment
57
Locations
1
Primary Endpoint
All-cause mortality
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The study will prospectively collect data from patients with Covid-19 admitted to the Västerås Intensive Care Unit, Västerås Hospital. Demographic, clinical, radiographic and laboratory characteristics will be recorded. Analysis of data to identify predictors of disease severity, mortality and treatment response.

Registry
clinicaltrials.gov
Start Date
March 26, 2020
End Date
November 12, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erland Ostberg

M.D., Ph.D.

Region Västmanland

Eligibility Criteria

Inclusion Criteria

  • •Patients admitted to the Intensive Care Unit with biological samples positive for SARS-CoV-
  • •Patients admitted to the Intensive Care Unit with one or more negative tests but with clinical and radiological characteristics highly suggestive of SARS-CoV-2 and thus considered positive for the disease.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

All-cause mortality

Time Frame: At 90 days follow-up after admittance to Intensive Care

Secondary Outcomes

  • Hospital length of stay(Until 90 days after admittance to Intensive Care)
  • Number of days on mechanical ventilation(Until 90 days after admittance to Intensive Care)
  • Number of patients receiving vasopressor support(Until 90 days after admittance to Intensive Care)
  • Number of patients receiving renal replacement therapy(Until 90 days after admittance to Intensive Care)
  • ICU length of stay(Until 90 days after admittance to Intensive Care)
  • Patient characteristics(At admission to ICU)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Outcomes of Patients With COVID-19 in the Intensive Care UnitCoronavirus InfectionsCOVID-19Viral Pneumonia Human Coronavirus
NCT04336345Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran150
Completed
Not Applicable
Clinical Characteristics of Critically Ill Patients With COVID-19Coronavirus InfectionCritical IllnessCharacteristics Disease
NCT04413435Nevsehir Public Hospital105
Completed
Not Applicable
Characteristics and Outcome of Patients With COVID-19 in ICUs in South TyrolCOVID-19COVID-19 Acute Respiratory Distress Syndrome
NCT05077319Institute of Mountain Emergency Medicine550
Completed
Not Applicable
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19Coronavirus Infection
NCT04343898Brigham and Women's Hospital5,154
Completed
Not Applicable
Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in ArgentinaRespiratory FailureCovid-19Mechanical Ventilation
NCT04611269Argentinian Intensive Care Society950